1. Academic Validation
  2. Outside-in engineering of cadherin endocytosis using a conformation strengthening antibody

Outside-in engineering of cadherin endocytosis using a conformation strengthening antibody

  • Nat Commun. 2025 Jan 29;16(1):1157. doi: 10.1038/s41467-025-56478-6.
Bin Xie # 1 Shipeng Xu # 2 Sanjeevi Sivasankar 3 4
Affiliations

Affiliations

  • 1 Biophysics Graduate Group, University of California, Davis, CA, USA.
  • 2 Department of Biomedical Engineering, University of California, Davis, CA, USA.
  • 3 Biophysics Graduate Group, University of California, Davis, CA, USA. ssivasankar@ucdavis.edu.
  • 4 Department of Biomedical Engineering, University of California, Davis, CA, USA. ssivasankar@ucdavis.edu.
  • # Contributed equally.
Abstract

P-cadherin, a crucial cell-cell adhesion protein which is overexpressed in numerous malignant cancers, is a popular target for drug delivery antibodies. However, molecular guidelines for engineering antibodies that can be internalized upon binding to P-cadherin are unknown. Here, we use a combination of biophysical, biochemical, and cell biological methods to demonstrate that trapping the P-cadherin extracellular region in an X-dimer adhesive conformation triggers Cadherin endocytosis via an outside-in signaling mechanism. We show that the anti-cancer drug delivery monoclonal antibody CQY684, traps P-cadherin in an X-dimer conformation and strengthens this adhesive structure. Formation of stable X-dimers results in the phosphorylation of p120-catenin, a suppressor of Cadherin endocytosis. This triggers the dissociation of p120-catenin from the X-dimer cytoplasmic region, which increases P-cadherin turnover and targets the cadherin-antibody complex to the lysosome. Our results establish an outside-in signaling mechanism that provides fundamental insights into how cells regulate adhesion and that can be exploited by anti-cadherin antibodies for intracellular drug delivery.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-P991342
    Anti-CDH3/P-cadherin mAb